BT
BMY icon

Banque Transatlantique’s Bristol-Myers Squibb BMY Stock Holding History

Banque Transatlantique’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$55.8K Hold
920
– – ﹤0.01% 303
2025
Q4 		$49.6K Sell
920
-800
-47% -$38.5K ﹤0.01% 162
2025
Q3 		$77.5K Sell
1,720
-250
-13% -$11.7K ﹤0.01% 151
2025
Q2 		$91.3K Hold
1,970
– – ﹤0.01% 139
2025
Q1 		$120K Hold
1,970
– – ﹤0.01% 126
2024
Q4 		$113K Buy
+1,970
New +$110K ﹤0.01% 132

Other funds holding BMY

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Banque Transatlantique's BMY Position: Q1 2026 in Review

Banque Transatlantique held its Bristol-Myers Squibb (BMY) position steady in Q1 2026 at 920 shares worth $55.8K. The position accounts for ﹤0.01% of the portfolio, ranked #303.

Banque Transatlantique first reported a position in BMY in Q4 2024 and has held it in 6 quarters since. The position peaked at $120K in Q1 2025. 2,519 funds tracked by Wall St. Rank hold BMY as of Q1 2026.

  • Banque Transatlantique held 920 shares of Bristol-Myers Squibb worth $55.8K as of Q1 2026.
  • Banque Transatlantique left its Bristol-Myers Squibb share count unchanged in Q1 2026.
  • Bristol-Myers Squibb made up ﹤0.01% of Banque Transatlantique's portfolio in Q1 2026, its #303 holding.
  • Banque Transatlantique first reported a position in Bristol-Myers Squibb in Q4 2024 and has held it in 6 quarters since.
  • Banque Transatlantique's Bristol-Myers Squibb position peaked at $120K in Q1 2025.
  • 2,519 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.

Based on Banque Transatlantique's 13F filing for Q1 2026, filed 13 May 2026.